<!DOCTYPE html>
<html lang="en"><head>
<script src="ateroskleroz-disi-damar-hastaliklari_files/libs/clipboard/clipboard.min.js"></script>
<script src="ateroskleroz-disi-damar-hastaliklari_files/libs/quarto-html/tabby.min.js"></script>
<script src="ateroskleroz-disi-damar-hastaliklari_files/libs/quarto-html/popper.min.js"></script>
<script src="ateroskleroz-disi-damar-hastaliklari_files/libs/quarto-html/tippy.umd.min.js"></script>
<link href="ateroskleroz-disi-damar-hastaliklari_files/libs/quarto-html/tippy.css" rel="stylesheet">
<link href="ateroskleroz-disi-damar-hastaliklari_files/libs/quarto-html/light-border.css" rel="stylesheet">
<link href="ateroskleroz-disi-damar-hastaliklari_files/libs/quarto-html/quarto-html.min.css" rel="stylesheet" data-mode="light">
<link href="ateroskleroz-disi-damar-hastaliklari_files/libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles"><meta charset="utf-8">
  <meta name="generator" content="quarto-1.3.340">

  <meta name="author" content="Serdar Balcı">
  <title>Title</title>
  <meta name="apple-mobile-web-app-capable" content="yes">
  <meta name="apple-mobile-web-app-status-bar-style" content="black-translucent">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no, minimal-ui">
  <link rel="stylesheet" href="ateroskleroz-disi-damar-hastaliklari_files/libs/revealjs/dist/reset.css">
  <link rel="stylesheet" href="ateroskleroz-disi-damar-hastaliklari_files/libs/revealjs/dist/reveal.css">
  <style>
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    div.columns{display: flex; gap: min(4vw, 1.5em);}
    div.column{flex: auto; overflow-x: auto;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    ul.task-list{list-style: none;}
    ul.task-list li input[type="checkbox"] {
      width: 0.8em;
      margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
      vertical-align: middle;
    }
  </style>
  <link rel="stylesheet" href="ateroskleroz-disi-damar-hastaliklari_files/libs/revealjs/dist/theme/quarto.css" id="theme">
  <link href="ateroskleroz-disi-damar-hastaliklari_files/libs/revealjs/plugin/quarto-line-highlight/line-highlight.css" rel="stylesheet">
  <link href="ateroskleroz-disi-damar-hastaliklari_files/libs/revealjs/plugin/reveal-menu/menu.css" rel="stylesheet">
  <link href="ateroskleroz-disi-damar-hastaliklari_files/libs/revealjs/plugin/reveal-menu/quarto-menu.css" rel="stylesheet">
  <link href="ateroskleroz-disi-damar-hastaliklari_files/libs/revealjs/plugin/quarto-support/footer.css" rel="stylesheet">
  <style type="text/css">

  .callout {
    margin-top: 1em;
    margin-bottom: 1em;  
    border-radius: .25rem;
  }

  .callout.callout-style-simple { 
    padding: 0em 0.5em;
    border-left: solid #acacac .3rem;
    border-right: solid 1px silver;
    border-top: solid 1px silver;
    border-bottom: solid 1px silver;
    display: flex;
  }

  .callout.callout-style-default {
    border-left: solid #acacac .3rem;
    border-right: solid 1px silver;
    border-top: solid 1px silver;
    border-bottom: solid 1px silver;
  }

  .callout .callout-body-container {
    flex-grow: 1;
  }

  .callout.callout-style-simple .callout-body {
    font-size: 1rem;
    font-weight: 400;
  }

  .callout.callout-style-default .callout-body {
    font-size: 0.9rem;
    font-weight: 400;
  }

  .callout.callout-titled.callout-style-simple .callout-body {
    margin-top: 0.2em;
  }

  .callout:not(.callout-titled) .callout-body {
      display: flex;
  }

  .callout:not(.no-icon).callout-titled.callout-style-simple .callout-content {
    padding-left: 1.6em;
  }

  .callout.callout-titled .callout-header {
    padding-top: 0.2em;
    margin-bottom: -0.2em;
  }

  .callout.callout-titled .callout-title  p {
    margin-top: 0.5em;
    margin-bottom: 0.5em;
  }
    
  .callout.callout-titled.callout-style-simple .callout-content  p {
    margin-top: 0;
  }

  .callout.callout-titled.callout-style-default .callout-content  p {
    margin-top: 0.7em;
  }

  .callout.callout-style-simple div.callout-title {
    border-bottom: none;
    font-size: .9rem;
    font-weight: 600;
    opacity: 75%;
  }

  .callout.callout-style-default  div.callout-title {
    border-bottom: none;
    font-weight: 600;
    opacity: 85%;
    font-size: 0.9rem;
    padding-left: 0.5em;
    padding-right: 0.5em;
  }

  .callout.callout-style-default div.callout-content {
    padding-left: 0.5em;
    padding-right: 0.5em;
  }

  .callout.callout-style-simple .callout-icon::before {
    height: 1rem;
    width: 1rem;
    display: inline-block;
    content: "";
    background-repeat: no-repeat;
    background-size: 1rem 1rem;
  }

  .callout.callout-style-default .callout-icon::before {
    height: 0.9rem;
    width: 0.9rem;
    display: inline-block;
    content: "";
    background-repeat: no-repeat;
    background-size: 0.9rem 0.9rem;
  }

  .callout-title {
    display: flex
  }
    
  .callout-icon::before {
    margin-top: 1rem;
    padding-right: .5rem;
  }

  .callout.no-icon::before {
    display: none !important;
  }

  .callout.callout-titled .callout-body > .callout-content > :last-child {
    margin-bottom: 0.5rem;
  }

  .callout.callout-titled .callout-icon::before {
    margin-top: .5rem;
    padding-right: .5rem;
  }

  .callout:not(.callout-titled) .callout-icon::before {
    margin-top: 1rem;
    padding-right: .5rem;
  }

  /* Callout Types */

  div.callout-note {
    border-left-color: #4582ec !important;
  }

  div.callout-note .callout-icon::before {
    background-image: url('data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAACAAAAAgCAYAAABzenr0AAAAAXNSR0IArs4c6QAAAERlWElmTU0AKgAAAAgAAYdpAAQAAAABAAAAGgAAAAAAA6ABAAMAAAABAAEAAKACAAQAAAABAAAAIKADAAQAAAABAAAAIAAAAACshmLzAAAEU0lEQVRYCcVXTWhcVRQ+586kSUMMxkyaElstCto2SIhitS5Ek8xUKV2poatCcVHtUlFQk8mbaaziwpWgglJwVaquitBOfhQXFlqlzSJpFSpIYyXNjBNiTCck7x2/8/LeNDOZxDuEkgOXe++553zfefee+/OYLOXFk3+1LLrRdiO81yNqZ6K9cG0P3MeFaMIQjXssE8Z1JzLO9ls20MBZX7oG8w9GxB0goaPrW5aNMp1yOZIa7Wv6o2ykpLtmAPs/vrG14Z+6d4jpbSKuhdcSyq9wGMPXjonwmESXrriLzFGOdDBLB8Y6MNYBu0dRokSygMA/mrun8MGFN3behm6VVAwg4WR3i6FvYK1T7MHo9BK7ydH+1uurECoouk5MPRyVSBrBHMYwVobG2aOXM07sWrn5qgB60rc6mcwIDJtQrnrEr44kmy+UO9r0u9O5/YbkS9juQckLed3DyW2XV/qWBBB3ptvI8EUY3I9p/67OW+g967TNr3Sotn3IuVlfMLVnsBwH4fsnebJvyGm5GeIUA3jljERmrv49SizPYuq+z7c2H/jlGC+Ghhupn/hcapqmcudB9jwJ/3jvnvu6vu5lVzF1fXyZuZZ7U8nRmVzytvT+H3kilYvH09mLWrQdwFSsFEsxFVs5fK7A0g8gMZjbif4ACpKbjv7gNGaD8bUrlk8x+KRflttr22JEMRUbTUwwDQScyzPgedQHZT0xnx7ujw2jfVfExwYHwOsDTjLdJ2ebmeQIlJ7neo41s/DrsL3kl+W2lWvAga0tR3zueGr6GL78M3ifH0rGXrBC2aAR8uYcIA5gwV8zIE8onoh8u0Fca/ciF7j1uOzEnqcIm59sEXoGc0+z6+H45V1CvAvHcD7THztu669cnp+L0okAeIc6zjbM/24LgGM1gZk7jnRu1aQWoU9sfUOuhrmtaPIO3YY1KLLWZaEO5TKUbMY5zx8W9UJ6elpLwKXbsaZ4EFl7B4bMtDv0iRipKoDQT2sNQI9b1utXFdYisi+wzZ/ri/1m7QfDgEuvgUUEIJPq3DhX/5DWNqIXDOweC2wvIR90Oq3lDpdMIgD2r0dXvGdsEW5H6x6HLRJYU7C69VefO1x8Gde1ZFSJLfWS1jbCnhtOPxmpfv2LXOA2Xk2tvnwKKPFuZ/oRmwBwqRQDcKNeVQkYcOjtWVBuM/JuYw5b6isojIkYxyYAFn5K7ZBF10fea52y8QltAg6jnMqNHFBmGkQ1j+U43HMi2xMar1Nv0zGsf1s8nUsmUtPOOrbFIR8bHFDMB5zL13Gmr/kGlCkUzedTzzmzsaJXhYawnA3UmARpiYj5ooJZiUoxFRtK3X6pgNPv+IZVPcnwbOl6f+aBaO1CNvPW9n9LmCp01nuSaTRF2YxHqZ8DYQT6WsXT+RD6eUztwYLZ8rM+rcPxamv1VQzFUkzFXvkiVrySGQgJNvXHJAxiU3/NwiC03rSf05VBaPtu/Z7/B8Yn/w7eguloAAAAAElFTkSuQmCC');
  }

  div.callout-note.callout-style-default .callout-title {
    background-color: #dae6fb
  }

  div.callout-important {
    border-left-color: #d9534f !important;
  }

  div.callout-important .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-important.callout-style-default .callout-title {
    background-color: #f7dddc
  }

  div.callout-warning {
    border-left-color: #f0ad4e !important;
  }

  div.callout-warning .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-warning.callout-style-default .callout-title {
    background-color: #fcefdc
  }

  div.callout-tip {
    border-left-color: #02b875 !important;
  }

  div.callout-tip .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-tip.callout-style-default .callout-title {
    background-color: #ccf1e3
  }

  div.callout-caution {
    border-left-color: #fd7e14 !important;
  }

  div.callout-caution .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-caution.callout-style-default .callout-title {
    background-color: #ffe5d0
  }

  </style>
  <style type="text/css">
    .reveal div.sourceCode {
      margin: 0;
      overflow: auto;
    }
    .reveal div.hanging-indent {
      margin-left: 1em;
      text-indent: -1em;
    }
    .reveal .slide:not(.center) {
      height: 100%;
      overflow-y: auto;
    }
    .reveal .slide.scrollable {
      overflow-y: auto;
    }
    .reveal .footnotes {
      height: 100%;
      overflow-y: auto;
    }
    .reveal .slide .absolute {
      position: absolute;
      display: block;
    }
    .reveal .footnotes ol {
      counter-reset: ol;
      list-style-type: none; 
      margin-left: 0;
    }
    .reveal .footnotes ol li:before {
      counter-increment: ol;
      content: counter(ol) ". "; 
    }
    .reveal .footnotes ol li > p:first-child {
      display: inline-block;
    }
    .reveal .slide ul,
    .reveal .slide ol {
      margin-bottom: 0.5em;
    }
    .reveal .slide ul li,
    .reveal .slide ol li {
      margin-top: 0.4em;
      margin-bottom: 0.2em;
    }
    .reveal .slide ul[role="tablist"] li {
      margin-bottom: 0;
    }
    .reveal .slide ul li > *:first-child,
    .reveal .slide ol li > *:first-child {
      margin-block-start: 0;
    }
    .reveal .slide ul li > *:last-child,
    .reveal .slide ol li > *:last-child {
      margin-block-end: 0;
    }
    .reveal .slide .columns:nth-child(3) {
      margin-block-start: 0.8em;
    }
    .reveal blockquote {
      box-shadow: none;
    }
    .reveal .tippy-content>* {
      margin-top: 0.2em;
      margin-bottom: 0.7em;
    }
    .reveal .tippy-content>*:last-child {
      margin-bottom: 0.2em;
    }
    .reveal .slide > img.stretch.quarto-figure-center,
    .reveal .slide > img.r-stretch.quarto-figure-center {
      display: block;
      margin-left: auto;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-left,
    .reveal .slide > img.r-stretch.quarto-figure-left  {
      display: block;
      margin-left: 0;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-right,
    .reveal .slide > img.r-stretch.quarto-figure-right  {
      display: block;
      margin-left: auto;
      margin-right: 0; 
    }
  </style>
</head>
<body class="quarto-light">
  <div class="reveal">
    <div class="slides">

<section id="title-slide" class="quarto-title-block center">
  <h1 class="title">Title</h1>

<div class="quarto-title-authors">
<div class="quarto-title-author">
<div class="quarto-title-author-name">
Serdar Balcı 
</div>
</div>
</div>

</section>
<section class="slide level2">


<img data-src="img%5CAteroskleroz-d%C4%B1s%CC%A7%C4%B1-damar-hastal%C4%B1klar%C4%B1pptx-kopyas%C4%B10.jpg" class="r-stretch"></section>
<section id="ateroskleroz-dısı-damar-hastalıkları" class="title-slide slide level1 center">
<h1>Ateroskleroz dışı damar hastalıkları</h1>

</section>

<section id="dr.-serdar-balci" class="title-slide slide level1 center">
<h1>Dr.&nbsp;Serdar BALCI</h1>

</section>

<section id="damar-patolojileri" class="title-slide slide level1 center">
<h1>Damar Patolojileri</h1>
<ul>
<li><strong>Damar lümeninde daralma ve tümüyle tıkanma</strong>
<ul>
<li><strong>Progresif</strong>
<ul>
<li><strong>Ateroskleroz</strong></li>
</ul></li>
<li><strong>Akut</strong>
<ul>
<li><strong>Tromboz veya tromboemboli</strong></li>
</ul></li>
</ul></li>
<li><strong>Damar duvarında zayıflama</strong>
<ul>
<li><strong>Dilatasyon, rüptür</strong></li>
</ul></li>
</ul>
<p><strong>Değişik amaçlar için değişik damarlar</strong></p>

<img data-src="img%5CAteroskleroz-d%C4%B1s%CC%A7%C4%B1-damar-hastal%C4%B1klar%C4%B1pptx-kopyas%C4%B11.png" class="r-stretch"><p><strong>Robbins Basic Pathology</strong></p>
</section>

<section id="damar-tabakaları" class="title-slide slide level1 center">
<h1>Damar tabakaları</h1>
<ul>
<li><strong>İntima</strong>
<ul>
<li><strong>Tek sıralı endotel hücre tabakası</strong></li>
<li><strong>Bazal membran</strong></li>
<li><strong>Lamina elastika interna</strong></li>
</ul></li>
<li><strong>Media</strong>
<ul>
<li><strong>Düz kas hücreleri ve ESM</strong></li>
<li><strong>Gevşek bağ doku, sinir lifleri, adventisyanın küçük damarları</strong></li>
<li><strong>Lamina elastika eksterna</strong></li>
</ul></li>
<li><strong>Adventisya</strong>
<ul>
<li><strong>Vazo vazorum</strong></li>
</ul></li>
</ul>
</section>

<section id="arterler" class="title-slide slide level1 center">
<h1>Arterler</h1>
<ul>
<li><strong>Büyük elastik arterler</strong>
<ul>
<li><strong>Aort, iliak ve pulmoner arterler</strong></li>
<li><strong>Media tabkasında düz kas hücreleri arasında elastik lifler</strong></li>
<li><strong>Sistolde genişleyip, diastolde tekrar daralmayı sağlar</strong></li>
<li><strong>İleri yaş, elastisite kaybolmuştur</strong>
<ul>
<li><strong>Distal organlara yüksek basınç iletilir</strong></li>
<li><strong>Dilate ve tortüyöz damarlar yırtılmaya yatkındır</strong></li>
</ul></li>
</ul></li>
<li><strong>Orta boy müsküler arterler</strong>
<ul>
<li><strong>Koroner ve renal arterler</strong></li>
<li><strong>Elastik lif sadece lamina elastika interna ve eksternada var</strong></li>
<li><strong>Media düz kas hücreleri var</strong>
<ul>
<li><strong>Lümen etrafında spiral ya da dairesel şekilde</strong></li>
</ul></li>
<li><strong>Bölgesel kan akımının düzenlenmesi</strong>
<ul>
<li><strong>Vazokonstürksiyon, vazodilatasyon</strong></li>
<li><strong>Atonom sinir sistemi, lokal metabolitler, asidoz</strong></li>
</ul></li>
</ul></li>
</ul>
<p><strong>Küçük arterler (&lt;2mm)</strong></p>
<p><strong>Arterioller (20-100 µm)</strong></p>
<p><strong>Organların bağ dokuları</strong></p>
<p><strong>Media çoğunlukla düz kas</strong></p>
<p><strong>Arterioller damar akışına karşı direnç oluştururular</strong></p>
<p><strong>Kan akımı belli bir hızda olur, atım şeklinde olmaz</strong></p>
</section>

<section id="kapillerler" class="title-slide slide level1 center">
<h1>Kapillerler</h1>
<p><strong>7-8µm, eritrosit kalınlığı</strong></p>
<p><strong>Endoteller döşeli</strong></p>
<p><strong>Düz kas benzeri hücreler → perisitler</strong></p>
<p><strong>Kan ve doku arasında difüzyon ile maddeler hızlıca değiştirilir</strong></p>
<p><strong>Oksijen ve besinler 100 µm ötesine difüzyonla taşınamaz</strong></p>
<p><strong>Metabolik oalrak aktif dokular (kalp) yüksek kapiller yoğunluğa sahiptir</strong></p>
</section>

<section id="venler" class="title-slide slide level1 center">
<h1>Venler</h1>
<ul>
<li><p><strong>Postkapiller venüller</strong></p>
<ul>
<li><strong>Ödem</strong></li>
<li><strong>Lökosit göçü</strong></li>
</ul></li>
<li><p><strong>Toplayıcı venüller</strong></p></li>
<li><p><strong>Büyük venler</strong></p></li>
<li><p><strong>Arterlerle kıyasla</strong></p>
<ul>
<li><strong>Venler geniş çap, geniş lümen, ince duvar, tabakalr daha az belirgin</strong></li>
</ul></li>
<li><p><strong>Dilatasyona, eksternal bası etkisine, infalamasyon ve tümör infiltrasyonuna yatkın</strong></p></li>
<li><p><strong>Venler kanın 2/3’ünü taşır</strong></p>
<ul>
<li><strong>Kapakçıklar yerçekimine karşı çalışır</strong></li>
</ul></li>
</ul>
</section>

<section id="lenfatikler" class="title-slide slide level1 center">
<h1>Lenfatikler</h1>
<p><strong>İnce duvarlı, endotelle döşeli kanallar</strong></p>
<p><strong>Fazla sıvı</strong></p>
<p><strong>Proteinler</strong></p>
<p><strong>Mononükleer hücreler</strong></p>
<p><strong>Tümörler ve infeksiyonlar</strong></p>

<img data-src="img%5CAteroskleroz-d%C4%B1s%CC%A7%C4%B1-damar-hastal%C4%B1klar%C4%B1pptx-kopyas%C4%B12.png" class="r-stretch"><p><strong>Robbins Basic Pathology</strong></p>
</section>

<section id="endotel" class="title-slide slide level1 center">
<h1>Endotel</h1>
<ul>
<li><p><strong>Kesintisiz tabaka halinde</strong></p></li>
<li><p><strong>Doku-kan arasında trombozu engelleyen tabaka</strong></p></li>
<li><p><strong>İnflamasyonu düzenler</strong></p></li>
<li><p><strong>Diğer hücrelerin büyümesini düzenler</strong></p>
<ul>
<li><strong>Düz kas hücreleri</strong></li>
</ul></li>
<li><p><strong>Vazoaktiviteyi düzenler</strong></p>
<ul>
<li><strong>Relaksasyon → Nitrik oksit</strong></li>
<li><strong>Konstriksiyon → Endotelin</strong></li>
</ul></li>
<li><p><strong>Interendotelyal bağlantılar</strong></p>
<ul>
<li><strong>Hemodinamik streste açılır (yüksek kan basıncı)</strong></li>
<li><strong>Vazoaktif ajanlarla açılır (histamin)</strong></li>
</ul></li>
<li><p><strong>Vakuoler transsitoz</strong></p></li>
<li><p><strong>İnflamasyon sırasında nötrofil geçişi</strong></p></li>
<li><p><strong>Karaciğer ve böbrekte filtrasyon için fenestrasyonları var</strong></p></li>
<li><p><strong>Kan beyin bariyerinde geçirgenlik yok</strong></p></li>
<li><p><strong>Trombozu engelleyici özelliği</strong></p>
<ul>
<li><strong>Laminar kan akımı</strong></li>
<li><strong>VEGF</strong></li>
<li><strong>Bazal membrana kuvvetli adhezyonu</strong></li>
</ul></li>
</ul>
</section>

<section id="endotelyal-aktivasyon" class="title-slide slide level1 center">
<h1>Endotelyal aktivasyon</h1>
<p><strong>Bakteriyal ürünler</strong></p>
<p><strong>İnflamatuar sitokinler</strong></p>
<p><strong>Hemodinamik stres</strong></p>
<p><strong>Lipid ürünleri (aterosekleroz)</strong></p>
<p><strong>İleri glikoliz ürünleri (diyabet)</strong></p>
<p><strong>Virüsler</strong></p>
<p><strong>Kompleman faktörleri</strong></p>
<p><strong>Metabolik uyaranlar (hipoksi)</strong></p>
</section>

<section id="aktive-endotelyal-hücreler" class="title-slide slide level1 center">
<h1>Aktive endotelyal hücreler</h1>
<ul>
<li><strong>Şekil değişikliği</strong></li>
<li><strong>Adhezyon molekülü eksprese ederler</strong></li>
<li><strong>Sitokinler, kemokinler, büyüme faktörleri, pro ve antikoagülan faktörler üretiler</strong></li>
<li><strong>Hızlı (dakikalar)</strong>
<ul>
<li><strong>Geri döüşen, yeni protein sentezi olmayan</strong></li>
<li><strong>Histamin ile endotellerin kontraksiyonu</strong></li>
</ul></li>
<li><strong>Günler</strong>
<ul>
<li><strong>Gen ve protein ekspresyonunda değişiklikler</strong></li>
</ul></li>
</ul>
</section>

<section id="endotel-disfonksiyonu" class="title-slide slide level1 center">
<h1>Endotel disfonksiyonu</h1>
<p><strong>Endotel bağlı vazodilatasyon</strong></p>
<p><strong>Hiperkoagülabilite durumları</strong></p>
<p><strong>Artmış serbset radikaller</strong></p>
<p><strong>Trombozu başlatır</strong></p>
<p><strong>Ateroskleroza yatkınlık</strong></p>
<p><strong>Hipertansiyon ve diyabetteki vasküler değişiklikler</strong></p>
</section>

<section id="vasküler-düz-kas-hücreleri" class="title-slide slide level1 center">
<h1>Vasküler düz kas hücreleri</h1>
<p><strong>Normal vasküler tamir</strong></p>
<p><strong>Ateroskleroz</strong></p>
<p><strong>Proliferasyon yeteneğine sahip</strong></p>
<p><strong>ESM kollojen, elastik ve proteoglikanını üretir</strong></p>
<p><strong>Büyüme faktörleri ve sitokinleri üretir</strong></p>
<p><strong>Vazokonstriksiyon ve vazodilatasyon</strong></p>
<ul>
<li><strong>Büyümeyi destekleyen</strong>
<ul>
<li><strong>Platelet kökenli büyüme faktörü (PDGF)</strong></li>
<li><strong>Endotelin</strong></li>
<li><strong>Trombin</strong></li>
<li><strong>Fibroblast büyüme faktörleri</strong></li>
<li><strong>İnflamatuar mediatörler</strong>
<ul>
<li><strong>İnterferon-γ (IFN-γ)</strong></li>
<li><strong>İnterlökin-1 (IL-1)</strong></li>
</ul></li>
</ul></li>
<li><strong>Sessiz durum</strong>
<ul>
<li><strong>Heparan sülfat</strong></li>
<li><strong>NO</strong></li>
<li><strong>Transforming growth factor-α (TGF-α)</strong></li>
</ul></li>
</ul>

<img data-src="img%5CAteroskleroz-d%C4%B1s%CC%A7%C4%B1-damar-hastal%C4%B1klar%C4%B1pptx-kopyas%C4%B13.png" class="r-stretch"><p><strong>Robbins Basic Pathology</strong></p>
</section>

<section id="berry-anevrizması" class="title-slide slide level1 center">
<h1>Berry anevrizması</h1>
<p><strong>Serebral damarlardan çıkan ince duvarlı anevrizmalar</strong></p>
<p><strong>Willis çemberinin dalları çevresinde</strong></p>
<p><strong>Arter mediası konjenital olarak incelmiştir</strong></p>
<p><strong>Spontan rüptür</strong></p>
<p><strong>Ölümcül intraserebral kanama</strong></p>
<p><img data-src="img%5CAteroskleroz-d%C4%B1s%CC%A7%C4%B1-damar-hastal%C4%B1klar%C4%B1pptx-kopyas%C4%B14.png"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CAteroskleroz-d%C4%B1s%CC%A7%C4%B1-damar-hastal%C4%B1klar%C4%B1pptx-kopyas%C4%B15.png"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
</section>

<section id="arteriovenöz-fistüller" class="title-slide slide level1 center">
<h1>Arteriovenöz fistüller</h1>
<ul>
<li><strong>Arter ve venler arasında anormal birleşimler</strong></li>
<li><strong>Arada kapiller yatak yok</strong></li>
<li><strong>Gelişim defekti</strong></li>
<li><strong>Atreryal anevrizmaların komşu venlere rüptürü</strong>
<ul>
<li><strong>Penetran yaralanma</strong></li>
<li><strong>Komşu damarlardaki inflamatuar nekroz</strong></li>
</ul></li>
<li><strong>Cerrahi → hemodiyaliz</strong></li>
<li><strong>Belirgin durumlarda → yüksek atımlı kalp yetmezliği</strong></li>
</ul>
</section>

<section id="fibromüsküler-displazi" class="title-slide slide level1 center">
<h1>Fibromüsküler displazi</h1>
<ul>
<li><strong>Orta ve geniş çaplı müsküler damarların fokal irregüler kalınlaşması</strong></li>
<li><strong>Medial, intimal hiperplazi ve fibrozis</strong></li>
<li><strong>Her yaşta olabilir, daha çok genç kadınlarda</strong></li>
<li><strong>Lümende stenoz</strong></li>
<li><strong>Anormal damar spazmı sonucu akım azalır</strong>
<ul>
<li><strong>Renovasküler hipertansiyon</strong></li>
</ul></li>
<li><strong>Fokal segmentler arasında damarlarda çıkıntılar ve rüptür</strong></li>
</ul>
</section>

<section id="raynaud-olgusu" class="title-slide slide level1 center">
<h1>Raynaud olgusu</h1>
<ul>
<li><strong>Arter ve arteriollerin aşırı vazokonstriksiyonu</strong></li>
<li><strong>Ekstremitelerde, el ve ayak parmaklarında</strong></li>
<li><strong>Burun, kulak ve dudaklarda</strong></li>
<li><strong>Paroksizmal solgunluk ve siyanoz</strong>
<ul>
<li><strong>Proksimalden distale kızarıklık, beyazlık ve mavilik</strong></li>
<li><strong>Proksimal vazodilatasyon, santral vazokonstriksiyon ve distalde siyanoz</strong></li>
</ul></li>
</ul>
</section>

<section id="primer-raynaud" class="title-slide slide level1 center">
<h1>Primer Raynaud</h1>
<ul>
<li><strong>Soğuk ve heyecana aşırı santral ve lokal vazomotor cevap</strong></li>
<li><strong>Genel popülasyonun %3-5’inda, genç kadınlarda</strong></li>
<li><strong>Damarlarda yapısal bozukluk yok</strong></li>
<li><strong>İleri hastalıklarda intimal kalınlaşma gözlenebilir</strong></li>
<li><strong>Genel gidiş iyi</strong></li>
<li><strong>Kronik durumda</strong>
<ul>
<li><strong>Deri, subkütan doku ve kaslarda atrofi</strong></li>
<li><strong>Ülserasyon ve iskemik hasar nadir</strong></li>
</ul></li>
</ul>
</section>

<section id="sekonder-raynaud" class="title-slide slide level1 center">
<h1>Sekonder Raynaud</h1>
<ul>
<li><strong>Arterial hastalıklara ikincil vasküler yetmezlik</strong>
<ul>
<li><strong>Sistemik lupus eritemaztozus</strong></li>
<li><strong>Skleroderma</strong></li>
<li><strong>Buerger hastalığı</strong></li>
<li><strong>Ateroskleroz</strong></li>
</ul></li>
</ul>
</section>

<section id="myokardial-damar-spazmı" class="title-slide slide level1 center">
<h1>Myokardial damar spazmı</h1>
<ul>
<li><strong>Belirgin konstriksiyon iskemiye neden olur</strong></li>
<li><strong>Sürekli vazospazm doku infarktına neden olur</strong></li>
<li><strong>Endojen</strong>
<ul>
<li><strong>Epinefrin, feokromorsitoma</strong></li>
</ul></li>
<li><strong>Eksojen</strong>
<ul>
<li><strong>Fenilefrini kokain</strong></li>
</ul></li>
<li><strong>Hipertiroidi dolaşımdaki katekolamine sensitiviteyi arttırır</strong></li>
<li><strong>Sklerodermadaki otoantikorlar ve T hücreleri vasküler instabiliteyi ve vazospazmı arttırır</strong></li>
<li><strong>Yoğun psikolojik stres</strong></li>
</ul>
<p><strong>Kardiak arter ve arteriollerdeki vazospasm (Kardiak Raynaud) 20-30 dakika sürerse → Myokard infarktüsü</strong></p>
<p><strong>Artmış katekolamin seviyeleri kalp hızını ve myokard kontraktilitesini arttırır → vazospazma ikincil iskemide artış</strong></p>
<p><strong>Ani kalp ölümü (Ölümcül aritmi)</strong></p>
<p><strong>İskemik dilate kardiyomyopati</strong></p>
</section>

<section id="ekstremitelerde-variköz-venler" class="title-slide slide level1 center">
<h1>Ekstremitelerde variköz venler</h1>
<p><strong>Anormal dilate, tortüyöz venler</strong></p>
<p><strong>Kronik artmış intraluminal basınç</strong></p>
<p><strong>Azalmış damar duvar desteği</strong></p>
<p><strong>Bacak ve uylukt süperfisyal damarlarda</strong></p>
<p><strong>Erkeklerin %20’si, kadınların 1/3’ü</strong></p>
<p><strong>Obezite, gebelik sırasında vena cava inferiora bası</strong></p>
<p><strong>Ailesel yatkınlık</strong></p>
<ul>
<li><strong>Venöz kapaklarda yetmezlik</strong></li>
<li><strong>Alt ekstremitelerde staz, konjesyon, ödem, ağrı ve tromboz</strong></li>
<li><strong>Ekstremitelerde süregiden ödem</strong></li>
<li><strong>Deride sekonder iskemik değişiklikler</strong>
<ul>
<li><strong>Staz dermatiti</strong></li>
<li><strong>Kronik variköz ülser</strong>
<ul>
<li><strong>Yavaş yara iyileşimi, infeksiyonlar</strong></li>
</ul></li>
</ul></li>
<li><strong>Bu süperfisyal damarlardan emboli çok nadir</strong></li>
</ul>
</section>

<section id="portal-sistem-konjesyonları" class="title-slide slide level1 center">
<h1>Portal sistem Konjesyonları</h1>
<ul>
<li><strong>Özefagus varisleri</strong>
<ul>
<li><strong>Karaciğer siroz</strong></li>
<li><strong>Portal ven obstrüksiyon</strong></li>
<li><strong>Hepatik ven trombozu</strong></li>
</ul></li>
<li><strong>Rektum</strong>
<ul>
<li><strong>Hemoroid</strong></li>
</ul></li>
<li><strong>Periumbilikal ven</strong>
<ul>
<li><strong>Kaput medusa</strong></li>
</ul></li>
</ul>
</section>

<section id="tromboflebit-ve-flebotromboz" class="title-slide slide level1 center">
<h1>Tromboflebit ve Flebotromboz</h1>
<p><strong>Tromboz ve inflamasyon</strong></p>
<p><strong>Derin bacak damarlar</strong></p>
<p><strong>Erkeklerde periprostatik venöz pleksus</strong></p>
<p><strong>Kadınlarda pelvik venöz pleksus</strong></p>
<p><strong>Kafatası içinde ve dural sinüslerdeki büyük damarlar</strong></p>
<p><strong>Periton infeksiyonları</strong></p>
<p><strong>Hiperkoagülabilite (Polisitemia vera)</strong></p>
</section>

<section id="bacaklarda-derin-ven-trombozu" class="title-slide slide level1 center">
<h1>Bacaklarda derin ven trombozu</h1>
<ul>
<li><strong>Uzamış immobilizasyon</strong>
<ul>
<li><strong>Uzamış yatak istirahati, yatalak</strong></li>
<li><strong>Uzun uçak ve otomobil yolculukları</strong></li>
<li><strong>Ameliyat sonrası</strong></li>
</ul></li>
<li><strong>Konjestif kalp yetmezliği</strong></li>
<li><strong>Gebelik</strong></li>
<li><strong>Oral kontraseptif kullanımı</strong></li>
<li><strong>Obezite</strong></li>
<li><strong>Kalıtımsal koagülasyon defektleri</strong></li>
<li><strong>Malign tümörlerin neden olduğu prokoagülan durum</strong>
<ul>
<li><strong>Migratuar tromboflebit, Trousseau sendromu</strong></li>
</ul></li>
<li><strong>Lokal bulgular</strong>
<ul>
<li><strong>Distal ödem</strong></li>
<li><strong>Siyanoz</strong></li>
<li><strong>Süperfisyal damar dilatasyonu</strong></li>
<li><strong>Sıcaklık artışı</strong></li>
<li><strong>Hassasiyet</strong></li>
<li><strong>Kızarıklık</strong></li>
<li><strong>Şişme</strong></li>
<li><strong>Ağrı</strong></li>
</ul></li>
<li><strong>Homan bulgusu</strong>
<ul>
<li><strong>Ayak kaslarını sıkarken, ayağa zorlu dorsifleksiyon yapınca ağrı</strong></li>
</ul></li>
<li><strong>Pulmoner emboli</strong></li>
</ul>
</section>

<section id="süperior-vena-cava-sendromu" class="title-slide slide level1 center">
<h1>Süperior vena cava sendromu</h1>
<p><strong>Süperior vena kavayı invaze eden ya da bası yapan neoplaziler</strong></p>
<p><strong>Bronkojenik karsinom</strong></p>
<p><strong>Mediastinal lenfoma</strong></p>
<p><strong>Kafa, boyun ve üst ekstremitede belirgin dilatasyon</strong></p>
<p><strong>Siyanoz</strong></p>
<p><strong>Pulmoner damarlara bası → Solunum sıkıntısı</strong></p>
</section>

<section id="inferior-vena-kava-sendromu" class="title-slide slide level1 center">
<h1>Inferior vena kava sendromu</h1>
<p><strong>İnferior vena kavaya bası yapan ya da infiltre eden neoplaziler</strong></p>
<p><strong>Hepatik, renal ve alt ekstremite venlerinde tromboz</strong></p>
<p><strong>Hepatoselüler karsinoma ve renal hücreli karsinom damar içinde büyümeye eğilimli</strong></p>
<p><strong>Belirgin alt ekstremite ödemi</strong></p>
<p><strong>Proteinüri</strong></p>
</section>

<section id="lenfanjit" class="title-slide slide level1 center">
<h1>Lenfanjit</h1>
<p><strong>Bakteriyel nedenli akut inflamasyon</strong></p>
<p><strong>Kırmızı, ağrılı subkütan çizgilenmeler</strong></p>
<p><strong>Drene eden lenf nodlarında hassas genişleme (akut lenfadenit)</strong></p>
<p><strong>Bakteremi, sepsis</strong></p>
</section>

<section id="lenfödem" class="title-slide slide level1 center">
<h1>Lenfödem</h1>
<ul>
<li><strong>Primer lenfödem</strong>
<ul>
<li><strong>İzole konjenita kayıp (basit konjenital lenfödem)</strong></li>
<li><strong>Familial Milroy hastalığı (Familial konjenital lenfödem)</strong>
<ul>
<li><strong>Lenfatiklerin agenezisi ya da hipoplazisi</strong></li>
</ul></li>
</ul></li>
<li><strong>Sekonder, obstrüktif lenfödem</strong>
<ul>
<li><strong>Lenfatik kanalları, lokal lenf nodlarını infiltre eden tümörler</strong></li>
<li><strong>Cerrahi işlemler</strong>
<ul>
<li><strong>Radikal mastektomi ile alınan aksiller lenf nodları</strong></li>
</ul></li>
<li><strong>Radyoterapi sonrası fibrozis</strong></li>
<li><strong>Filariazis</strong></li>
<li><strong>Postinflamatuar tromboz ve skar</strong></li>
</ul></li>
<li><strong>Ödem</strong></li>
<li><strong>Kronik ödem</strong>
<ul>
<li><strong>ESM birikimi ve fibrozis</strong></li>
<li><strong>Kahverengi ve peau d’orange benzeri görünüm</strong></li>
<li><strong>Yetersiz doku perfüzyonu</strong></li>
<li><strong>Deri ülserasyonu</strong></li>
<li><strong>Dilate lenfatiklerin rüptürü</strong></li>
<li><strong>Boşluklarda süt benzeri lenf içeriği birikimi</strong>
<ul>
<li><strong>Şilöz assit (batın), şilotoraks, şiloperikardium</strong></li>
</ul></li>
</ul></li>
</ul>

<img data-src="img%5CAteroskleroz-d%C4%B1s%CC%A7%C4%B1-damar-hastal%C4%B1klar%C4%B1pptx-kopyas%C4%B16.png" class="r-stretch"><p><strong>Robbins Basic Pathology</strong></p>
</section>

<section id="damar-tümörleri" class="title-slide slide level1 center">
<h1>Damar tümörleri</h1>
<ul>
<li><strong>Büyük damarların primer tümörleri</strong>
<ul>
<li><strong>Oldukça nadir ve çoğunlukla sarkom</strong></li>
</ul></li>
<li><strong>Benign tümörler</strong>
<ul>
<li><strong>Belirigin kan ya da lenf dolu damarlar</strong></li>
<li><strong>Tek sıralı normal görünümlü damarlar</strong></li>
</ul></li>
<li><strong>Malign tümörler</strong>
<ul>
<li><strong>Daha selüler</strong></li>
<li><strong>Sitolojik atipi</strong></li>
<li><strong>Proliferatif</strong></li>
<li><strong>İyi organize damarlar yok</strong></li>
<li><strong>İmmünohistokimya ile ayırt edilebilir</strong>
<ul>
<li><strong>CD31, von Willebrand factor</strong></li>
</ul></li>
</ul></li>
</ul>
</section>

<section id="damar-ektazileri" class="title-slide slide level1 center">
<h1>Damar ektazileri</h1>
<ul>
<li><strong>Damar dilatasyonu</strong>
<ul>
<li><strong>Konjenital ya d akkiz</strong></li>
<li><strong>Gerçek neoplazi değiller</strong></li>
</ul></li>
<li><strong>Nevus flammeus (doğum lekesi)</strong></li>
<li><strong>Port wine stain, Sturge-Weber sendromu</strong></li>
<li><strong>Spider telenjiektazi, gebelik, siroz</strong></li>
<li><strong>Herediter hemorajik talenjiektazi (Osler-Weber-Rendu hastalığı)</strong></li>
</ul>
</section>

<section id="kapiller-hemanjiom" class="title-slide slide level1 center">
<h1>Kapiller hemanjiom</h1>
<p><strong>En sık tip</strong></p>
<p><strong>Deri</strong></p>
<p><strong>Subkütan doku</strong></p>
<p><strong>Oral kavite ve dudaklarda müköz membranlarda</strong></p>
<p><strong>Karaciğer, dalak ve böbrekler</strong></p>
<p><strong>İnce duvarlı damarlar, az stroma</strong></p>
<p><img data-src="img%5CAteroskleroz-d%C4%B1s%CC%A7%C4%B1-damar-hastal%C4%B1klar%C4%B1pptx-kopyas%C4%B17.png"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CAteroskleroz-d%C4%B1s%CC%A7%C4%B1-damar-hastal%C4%B1klar%C4%B1pptx-kopyas%C4%B18.png"></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>

<section id="juvenil-hemanjiom-çilek-hemanjiom" class="title-slide slide level1 center">
<h1>Juvenil hemanjiomÇilek hemanjiom</h1>
<p><strong>Yenideoğan derisi</strong></p>
<p><strong>Sık (1:200 doğum)</strong></p>
<p><strong>Multiple olabilir</strong></p>
<p><strong>İlk birkaç ay hızlı büyür, 1-3 yaş arası silinmeye başlar, 7 yaşta kaybolur</strong></p>
</section>

<section id="piyojenik-granülom" class="title-slide slide level1 center">
<h1>Piyojenik granülom</h1>
<p><strong>Kapiller hemanjiom</strong></p>
<p><strong>Hızlı büyüyen, saplı, deri, dişeti ve oral mukozada görülen kırmızı lezyonlar</strong></p>
<p><strong>Abartılı granülasyon dokusuna benzer</strong></p>
<p><strong>Kolay kanar ve genellikle ülsere</strong></p>
<p><strong>Travma sonrası gelişir, birkaç haftada 1-2 cm ulaşır</strong></p>

<img data-src="img%5CAteroskleroz-d%C4%B1s%CC%A7%C4%B1-damar-hastal%C4%B1klar%C4%B1pptx-kopyas%C4%B19.png" class="r-stretch"><p><strong>Robbins Basic Pathology</strong></p>
</section>

<section id="kavernöz-hemanjiom" class="title-slide slide level1 center">
<h1>Kavernöz hemanjiom</h1>
<p><strong>İri, dilate vasküler yapılar, konnektif doku ile ayrılır</strong></p>
<p><strong>Daha infiltratif, derin yapıları infiltre eder</strong></p>
<p><strong>Spontan regresyon olmaz</strong></p>
<p><strong>İyi sınırlı, kapsülsüz</strong></p>
<p><strong>İntravsküler tromboz, distrofik kalsifikasyon görülür</strong></p>

<img data-src="img%5CAteroskleroz-d%C4%B1s%CC%A7%C4%B1-damar-hastal%C4%B1klar%C4%B1pptx-kopyas%C4%B110.png" class="r-stretch"><p><strong>Robbins Basic Pathology</strong></p>
</section>

<section id="lenfanjiom" class="title-slide slide level1 center">
<h1>Lenfanjiom</h1>
<ul>
<li><strong>Basit (kapiller) lenfanjiom</strong>
<ul>
<li><strong>Baş, boyun, aksiller subkütenöz doku</strong></li>
</ul></li>
<li><strong>Kavernöz lenfanjiom (kistik higroma)</strong>
<ul>
<li><strong>Çocukların boyun ve aksillasında, nadiren retroperitonda</strong></li>
<li><strong>Çok büyük olabilir (15 cm’e kadar)</strong></li>
<li><strong>Turner sendromunda sık</strong></li>
<li><strong>Lenfoid agregat içeren stroması var</strong></li>
<li><strong>Sınırları düzensiz, kapsülsüz, definitif rezeksiyon zor</strong></li>
</ul></li>
</ul>
</section>

<section id="glomus-tümör-glomanjiom" class="title-slide slide level1 center">
<h1>Glomus Tümör (Glomanjiom)</h1>
<p><strong>Benign, ağrılı tümörler</strong></p>
<p><strong>Glomus cisimciklerden köken alır</strong></p>
<p><strong>Arteriovenöz yapılardaki termoregülasyon</strong></p>
<p><strong>Parmaklarda, tırnak yatağında</strong></p>
<p><strong>Eksizyon ile tedavi edilir</strong></p>
</section>

<section id="basiller-anjiomatozis" class="title-slide slide level1 center">
<h1>Basiller anjiomatozis</h1>
<p><strong>AIDS hastalarında</strong></p>
<p><strong>Opportunist Gram negatif Bartonella basillerinin infeksiyonu</strong></p>
<p><strong>Deri, kemik, beyin, diğer organ</strong></p>
<p><strong>Deride kırmızı papül ve nodüller, yuvarlak subkütan kitleler</strong></p>
<p><strong>Epitelioid endotel hücrelerinin proliferasyonu</strong></p>
<p><strong>Nükleer atipi ve mitoz</strong></p>
<p><strong>Bakteri dokuların HIF-1α ve VEGF üretimini arttırıyor, vasküler proliferasyona neden oluyor</strong></p>
<p><strong>Antibiyotik ile tedavi edilir</strong></p>
<p><img data-src="img%5CAteroskleroz-d%C4%B1s%CC%A7%C4%B1-damar-hastal%C4%B1klar%C4%B1pptx-kopyas%C4%B111.png"></p>
<p><strong>Bacillary angiomatosis.</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CAteroskleroz-d%C4%B1s%CC%A7%C4%B1-damar-hastal%C4%B1klar%C4%B1pptx-kopyas%C4%B112.png"></p>
<p><strong>Bacillary angiomatosis.</strong></p>
<p><strong>B: Histologic features are those of acute inflammation and capillary proliferation. Inset, Modified silver (Warthin-Starry) stain demonstrates clusters of tangled bacilli (black)</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>

<section id="kaposi-sarkomu" class="title-slide slide level1 center">
<h1>Kaposi Sarkomu</h1>
<ul>
<li><strong>HHV-8</strong></li>
<li><strong>Yaşlılarda klaisk form</strong></li>
<li><strong>AIDS ilişkili</strong></li>
<li><strong>Transplant ilişkili</strong></li>
<li><strong>KSHV (HHV8) γ-herpesvirus</strong>
<ul>
<li><strong>Cinsel, cinsel olmayan yolla bulaşır</strong></li>
</ul></li>
<li><strong>T hücre immünitesinde değişiklik</strong></li>
<li><strong>Endotellerde litik ve latent enfeksiyonlar</strong></li>
<li><strong>Viral G protein VEGF üretimini uyarır</strong></li>
<li><strong>Cyclin D’in viral homologu proliferasyona neden olur</strong></li>
<li><strong>Yama, plak, nodüler fazları</strong></li>
</ul>
<p><img data-src="img%5CAteroskleroz-d%C4%B1s%CC%A7%C4%B1-damar-hastal%C4%B1klar%C4%B1pptx-kopyas%C4%B113.png"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CAteroskleroz-d%C4%B1s%CC%A7%C4%B1-damar-hastal%C4%B1klar%C4%B1pptx-kopyas%C4%B114.png"></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>

<section id="hemanjioendotelyom" class="title-slide slide level1 center">
<h1>Hemanjioendotelyom</h1>
<p><strong>İntermediate derece neoplazi</strong></p>
<p><strong>Epiteloid formu var</strong></p>
<p><strong>Eksizyon çoğu vakada kür</strong></p>
<p><strong>%40 rekürrens</strong></p>
<p><strong>%20-30 metastaz</strong></p>
<p><strong>%15 tümör ilişkili ölüm</strong></p>
</section>

<section id="anjiosarkom" class="title-slide slide level1 center">
<h1>Anjiosarkom</h1>
<p><strong>Malign endotelyal neoplazi</strong></p>
<p><strong>Hemanjioma benzeyen iyi diferansiye tümörler, anaplastik tümörlere kadar değişen morfoloji</strong></p>
<p><strong>Yaşlılarda</strong></p>
<p><strong>Cinsiyet farkı yok</strong></p>
<p><strong>Heryerde olabilir, en sık deri, yumuşak doku, meme, karaciğer</strong></p>
<ul>
<li><p><strong>Hepatik anjiosarkom</strong></p>
<ul>
<li><strong>Arsenik içeren böcek ilaçları</strong></li>
<li><strong>Thorotrast</strong>
<ul>
<li><strong>Eskiden kullanılan radyoaktif kontrast maddesi</strong></li>
</ul></li>
<li><strong>Polivinil klorid</strong></li>
</ul></li>
<li><p><strong>Lenfödemli hastalarda</strong></p>
<ul>
<li><strong>Meme tümörlerinde aksiller lenf nodu rezeksiyonu</strong></li>
<li><strong>Lenfanjiosarkom</strong></li>
</ul></li>
<li><p><strong>Radsayon sonrası olabilir</strong></p></li>
<li><p><strong>Uzun yıllar olan yabancı cisim (kateter)</strong></p></li>
<li><p><strong>Deri</strong></p>
<ul>
<li><strong>Küçük, iyi sınırlı asemptomatik kırmızı nodül olarak başlar</strong></li>
<li><strong>İleri lezyonlar</strong>
<ul>
<li><strong>Büyük, etsi kırmızı-ten rengi, gri-beyaz kitleler</strong></li>
<li><strong>Nekroz ve kanama</strong></li>
</ul></li>
</ul></li>
<li><p><strong>Lokal agresif ve metastaz</strong></p></li>
<li><p><strong>5 yıllık sağkalım %30</strong></p></li>
</ul>
<p><img data-src="img%5CAteroskleroz-d%C4%B1s%CC%A7%C4%B1-damar-hastal%C4%B1klar%C4%B1pptx-kopyas%C4%B115.png"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CAteroskleroz-d%C4%B1s%CC%A7%C4%B1-damar-hastal%C4%B1klar%C4%B1pptx-kopyas%C4%B116.png"></p>
<p><img data-src="img%5CAteroskleroz-d%C4%B1s%CC%A7%C4%B1-damar-hastal%C4%B1klar%C4%B1pptx-kopyas%C4%B117.png"></p>
<p><strong>Moderately differentiated angiosarcoma with dense clumps of atypical cells lining distinct vascular lumina</strong></p>
<p><strong>Immunohistochemical staining of angiosarcoma for the endothelial cell marker CD31</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>

<section id="vasküler-girişimler" class="title-slide slide level1 center">
<h1>Vasküler girişimler</h1>
<p><strong>Tromboz, intimal kalınlaşma ateroskleroz stent ya da greft sonrası görülebilir</strong></p>

<img data-src="img%5CAteroskleroz-d%C4%B1s%CC%A7%C4%B1-damar-hastal%C4%B1klar%C4%B1pptx-kopyas%C4%B118.png" class="r-stretch"><p><strong>Robbins Basic Pathology</strong></p>
<div class="footer footer-default">

</div>
</section>
    </div>
  </div>

  <script>window.backupDefine = window.define; window.define = undefined;</script>
  <script src="ateroskleroz-disi-damar-hastaliklari_files/libs/revealjs/dist/reveal.js"></script>
  <!-- reveal.js plugins -->
  <script src="ateroskleroz-disi-damar-hastaliklari_files/libs/revealjs/plugin/quarto-line-highlight/line-highlight.js"></script>
  <script src="ateroskleroz-disi-damar-hastaliklari_files/libs/revealjs/plugin/pdf-export/pdfexport.js"></script>
  <script src="ateroskleroz-disi-damar-hastaliklari_files/libs/revealjs/plugin/reveal-menu/menu.js"></script>
  <script src="ateroskleroz-disi-damar-hastaliklari_files/libs/revealjs/plugin/reveal-menu/quarto-menu.js"></script>
  <script src="ateroskleroz-disi-damar-hastaliklari_files/libs/revealjs/plugin/quarto-support/support.js"></script>
  

  <script src="ateroskleroz-disi-damar-hastaliklari_files/libs/revealjs/plugin/notes/notes.js"></script>
  <script src="ateroskleroz-disi-damar-hastaliklari_files/libs/revealjs/plugin/search/search.js"></script>
  <script src="ateroskleroz-disi-damar-hastaliklari_files/libs/revealjs/plugin/zoom/zoom.js"></script>
  <script src="ateroskleroz-disi-damar-hastaliklari_files/libs/revealjs/plugin/math/math.js"></script>
  <script>window.define = window.backupDefine; window.backupDefine = undefined;</script>

  <script>

      // Full list of configuration options available at:
      // https://revealjs.com/config/
      Reveal.initialize({
'controlsAuto': true,
'previewLinksAuto': false,
'smaller': false,
'pdfSeparateFragments': false,
'autoAnimateEasing': "ease",
'autoAnimateDuration': 1,
'autoAnimateUnmatched': true,
'menu': {"side":"left","useTextContentForMissingTitles":true,"markers":false,"loadIcons":false,"custom":[{"title":"Tools","icon":"<i class=\"fas fa-gear\"></i>","content":"<ul class=\"slide-menu-items\">\n<li class=\"slide-tool-item active\" data-item=\"0\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.fullscreen(event)\"><kbd>f</kbd> Fullscreen</a></li>\n<li class=\"slide-tool-item\" data-item=\"1\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.speakerMode(event)\"><kbd>s</kbd> Speaker View</a></li>\n<li class=\"slide-tool-item\" data-item=\"2\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.overview(event)\"><kbd>o</kbd> Slide Overview</a></li>\n<li class=\"slide-tool-item\" data-item=\"3\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.togglePdfExport(event)\"><kbd>e</kbd> PDF Export Mode</a></li>\n<li class=\"slide-tool-item\" data-item=\"4\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.keyboardHelp(event)\"><kbd>?</kbd> Keyboard Help</a></li>\n</ul>"}],"openButton":true},
'smaller': false,
 
        // Display controls in the bottom right corner
        controls: false,

        // Help the user learn the controls by providing hints, for example by
        // bouncing the down arrow when they first encounter a vertical slide
        controlsTutorial: false,

        // Determines where controls appear, "edges" or "bottom-right"
        controlsLayout: 'edges',

        // Visibility rule for backwards navigation arrows; "faded", "hidden"
        // or "visible"
        controlsBackArrows: 'faded',

        // Display a presentation progress bar
        progress: true,

        // Display the page number of the current slide
        slideNumber: false,

        // 'all', 'print', or 'speaker'
        showSlideNumber: 'all',

        // Add the current slide number to the URL hash so that reloading the
        // page/copying the URL will return you to the same slide
        hash: true,

        // Start with 1 for the hash rather than 0
        hashOneBasedIndex: false,

        // Flags if we should monitor the hash and change slides accordingly
        respondToHashChanges: true,

        // Push each slide change to the browser history
        history: true,

        // Enable keyboard shortcuts for navigation
        keyboard: true,

        // Enable the slide overview mode
        overview: true,

        // Disables the default reveal.js slide layout (scaling and centering)
        // so that you can use custom CSS layout
        disableLayout: false,

        // Vertical centering of slides
        center: false,

        // Enables touch navigation on devices with touch input
        touch: true,

        // Loop the presentation
        loop: false,

        // Change the presentation direction to be RTL
        rtl: false,

        // see https://revealjs.com/vertical-slides/#navigation-mode
        navigationMode: 'linear',

        // Randomizes the order of slides each time the presentation loads
        shuffle: false,

        // Turns fragments on and off globally
        fragments: true,

        // Flags whether to include the current fragment in the URL,
        // so that reloading brings you to the same fragment position
        fragmentInURL: false,

        // Flags if the presentation is running in an embedded mode,
        // i.e. contained within a limited portion of the screen
        embedded: false,

        // Flags if we should show a help overlay when the questionmark
        // key is pressed
        help: true,

        // Flags if it should be possible to pause the presentation (blackout)
        pause: true,

        // Flags if speaker notes should be visible to all viewers
        showNotes: false,

        // Global override for autoplaying embedded media (null/true/false)
        autoPlayMedia: null,

        // Global override for preloading lazy-loaded iframes (null/true/false)
        preloadIframes: null,

        // Number of milliseconds between automatically proceeding to the
        // next slide, disabled when set to 0, this value can be overwritten
        // by using a data-autoslide attribute on your slides
        autoSlide: 0,

        // Stop auto-sliding after user input
        autoSlideStoppable: true,

        // Use this method for navigation when auto-sliding
        autoSlideMethod: null,

        // Specify the average time in seconds that you think you will spend
        // presenting each slide. This is used to show a pacing timer in the
        // speaker view
        defaultTiming: null,

        // Enable slide navigation via mouse wheel
        mouseWheel: false,

        // The display mode that will be used to show slides
        display: 'block',

        // Hide cursor if inactive
        hideInactiveCursor: true,

        // Time before the cursor is hidden (in ms)
        hideCursorTime: 5000,

        // Opens links in an iframe preview overlay
        previewLinks: false,

        // Transition style (none/fade/slide/convex/concave/zoom)
        transition: 'none',

        // Transition speed (default/fast/slow)
        transitionSpeed: 'default',

        // Transition style for full page slide backgrounds
        // (none/fade/slide/convex/concave/zoom)
        backgroundTransition: 'none',

        // Number of slides away from the current that are visible
        viewDistance: 3,

        // Number of slides away from the current that are visible on mobile
        // devices. It is advisable to set this to a lower number than
        // viewDistance in order to save resources.
        mobileViewDistance: 2,

        // The "normal" size of the presentation, aspect ratio will be preserved
        // when the presentation is scaled to fit different resolutions. Can be
        // specified using percentage units.
        width: 1050,

        height: 700,

        // Factor of the display size that should remain empty around the content
        margin: 0.1,

        math: {
          mathjax: 'https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.0/MathJax.js',
          config: 'TeX-AMS_HTML-full',
          tex2jax: {
            inlineMath: [['\\(','\\)']],
            displayMath: [['\\[','\\]']],
            balanceBraces: true,
            processEscapes: false,
            processRefs: true,
            processEnvironments: true,
            preview: 'TeX',
            skipTags: ['script','noscript','style','textarea','pre','code'],
            ignoreClass: 'tex2jax_ignore',
            processClass: 'tex2jax_process'
          },
        },

        // reveal.js plugins
        plugins: [QuartoLineHighlight, PdfExport, RevealMenu, QuartoSupport,

          RevealMath,
          RevealNotes,
          RevealSearch,
          RevealZoom
        ]
      });
    </script>
    <script id="quarto-html-after-body" type="application/javascript">
    window.document.addEventListener("DOMContentLoaded", function (event) {
      const toggleBodyColorMode = (bsSheetEl) => {
        const mode = bsSheetEl.getAttribute("data-mode");
        const bodyEl = window.document.querySelector("body");
        if (mode === "dark") {
          bodyEl.classList.add("quarto-dark");
          bodyEl.classList.remove("quarto-light");
        } else {
          bodyEl.classList.add("quarto-light");
          bodyEl.classList.remove("quarto-dark");
        }
      }
      const toggleBodyColorPrimary = () => {
        const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
        if (bsSheetEl) {
          toggleBodyColorMode(bsSheetEl);
        }
      }
      toggleBodyColorPrimary();  
      const tabsets =  window.document.querySelectorAll(".panel-tabset-tabby")
      tabsets.forEach(function(tabset) {
        const tabby = new Tabby('#' + tabset.id);
      });
      const isCodeAnnotation = (el) => {
        for (const clz of el.classList) {
          if (clz.startsWith('code-annotation-')) {                     
            return true;
          }
        }
        return false;
      }
      const clipboard = new window.ClipboardJS('.code-copy-button', {
        text: function(trigger) {
          const codeEl = trigger.previousElementSibling.cloneNode(true);
          for (const childEl of codeEl.children) {
            if (isCodeAnnotation(childEl)) {
              childEl.remove();
            }
          }
          return codeEl.innerText;
        }
      });
      clipboard.on('success', function(e) {
        // button target
        const button = e.trigger;
        // don't keep focus
        button.blur();
        // flash "checked"
        button.classList.add('code-copy-button-checked');
        var currentTitle = button.getAttribute("title");
        button.setAttribute("title", "Copied!");
        let tooltip;
        if (window.bootstrap) {
          button.setAttribute("data-bs-toggle", "tooltip");
          button.setAttribute("data-bs-placement", "left");
          button.setAttribute("data-bs-title", "Copied!");
          tooltip = new bootstrap.Tooltip(button, 
            { trigger: "manual", 
              customClass: "code-copy-button-tooltip",
              offset: [0, -8]});
          tooltip.show();    
        }
        setTimeout(function() {
          if (tooltip) {
            tooltip.hide();
            button.removeAttribute("data-bs-title");
            button.removeAttribute("data-bs-toggle");
            button.removeAttribute("data-bs-placement");
          }
          button.setAttribute("title", currentTitle);
          button.classList.remove('code-copy-button-checked');
        }, 1000);
        // clear code selection
        e.clearSelection();
      });
      function tippyHover(el, contentFn) {
        const config = {
          allowHTML: true,
          content: contentFn,
          maxWidth: 500,
          delay: 100,
          arrow: false,
          appendTo: function(el) {
              return el.closest('section.slide') || el.parentElement;
          },
          interactive: true,
          interactiveBorder: 10,
          theme: 'light-border',
          placement: 'bottom-start'
        };
          config['offset'] = [0,0];
          config['maxWidth'] = 700;
        window.tippy(el, config); 
      }
      const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
      for (var i=0; i<noterefs.length; i++) {
        const ref = noterefs[i];
        tippyHover(ref, function() {
          // use id or data attribute instead here
          let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
          try { href = new URL(href).hash; } catch {}
          const id = href.replace(/^#\/?/, "");
          const note = window.document.getElementById(id);
          return note.innerHTML;
        });
      }
      const findCites = (el) => {
        const parentEl = el.parentElement;
        if (parentEl) {
          const cites = parentEl.dataset.cites;
          if (cites) {
            return {
              el,
              cites: cites.split(' ')
            };
          } else {
            return findCites(el.parentElement)
          }
        } else {
          return undefined;
        }
      };
      var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
      for (var i=0; i<bibliorefs.length; i++) {
        const ref = bibliorefs[i];
        const citeInfo = findCites(ref);
        if (citeInfo) {
          tippyHover(citeInfo.el, function() {
            var popup = window.document.createElement('div');
            citeInfo.cites.forEach(function(cite) {
              var citeDiv = window.document.createElement('div');
              citeDiv.classList.add('hanging-indent');
              citeDiv.classList.add('csl-entry');
              var biblioDiv = window.document.getElementById('ref-' + cite);
              if (biblioDiv) {
                citeDiv.innerHTML = biblioDiv.innerHTML;
              }
              popup.appendChild(citeDiv);
            });
            return popup.innerHTML;
          });
        }
      }
    });
    </script>
    

</body></html>